In a recent animal study, TNF blockade was found to attenuate the development of colitis and colorectal cancer, mainly involving anti-inflammatory effects, reduced DNA damage response to colonic crypt regeneration, altered gut microbiota in mice, and functionally attenuated colorectal cancer development (Yang et al., 2020). The gene discussed is TNF; the disease is colitis.